Please wait
0001812364424B5EX-FILING FEESfalse 0001812364 2024-09-10 2024-09-10 0001812364 1 2024-09-10 2024-09-10 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Relay Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
     Security
Type
   Security
Class Title
   Fee
Calculation
or Fee
Carry
Forward
Rule
   Amount
Registered
   Proposed
Maximum
Offering
Price
   Maximum
Aggregate
Offering
Price
   Fee Rate    Amount of
Registration
Fee
   Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
Newly Registered Securities
Fees to Be
Paid
   Equity    Common Stock, $0.001 per share    457(r)    32,857,143    —     $230,000,001.00    0.00014760    $33,948.01
(1)
    
Fees
Previously
Paid
   —     —     —     —     —     —     —     —      
Carry Forward Securities
Carry
Forward
Securities
   —     —     —     —     —     —     —     —     — 
    
Total Offering Amounts
        $230,000,001.00        
$33,948.01
    
    
Total Fees Previously Paid
                      
    
Total Fee Offsets
                      
    
Net Fee Due
                 
$33,948.01
    
 
(1)
Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). The fee payable in connection with the offering pursuant to this prospectus supplement has been paid in accordance with Rule 456(b) under the Securities Act, and represents deferred payment of the registration fees in connection with the registrant’s Registration Statement on Form
S-3ASR
(Registration
No. 333-281308).